首页> 外文期刊>International journal of oncology >P2Y 2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer
【24h】

P2Y 2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer

机译:P2Y 2 R介导的炎性小体激活与乳腺癌细胞和耐放射治疗的乳腺癌的肿瘤进展有关

获取原文
       

摘要

In the tumor microenvironment, extracellular nucleotides are released and accumulate, and can activate the P2Y _(2) receptor (P2Y _(2)R), which regulates various responses in tumor cells, resulting in tumor progression and metastasis. Moreover, the inflammasome has recently been reported to be associated with tumor progression. However, the role of P2Y _(2)R in inflammasome activation in breast cancer cells is not yet well defined. Therefore, in this study, we investigated the role of P2Y _(2)R in inflammasome-mediated tumor progression in breast cancer using breast cancer cells and radiotherapy-resistant (RT-R) breast cancer cells. We established RT-R-breast cancer cells (RT-R-MDA-MB-231, RT-R-MCF-7, and RT-R-T47D cells) by repeated irradiation (2 Gy each, 25 times) in a previous study. In this study, we found that the RT-R breast cancer cells exhibited an increased release of adenosine triphosphate (ATP) and P2Y _(2)R activity. In particular, the RT-R-MDA-MB-231 cells derived from highly metastatic MDA-MB-231 cells, exhibited a markedly increased ATP release, which was potentiated by tumor necrosis factor (TNF)-α. The MDA-MB-231 cells exhibited inflammasome activation, as measured by caspase-1 activity and interleukin (IL)-1β secretion following treatment with TNF-α and ATP; these effects were enhanced in the RT-R-MDA-MB-231 cells. However, the increased caspase-1 activities and IL-1β secretion levels induced in response to treatment with TNF-α or ATP were significantly reduced by P2Y _(2)R knockdown or the presence of apyrase in both the MDA-MB-231 and RT-R-MDA-MB-231 cells, suggesting the involvement of ATP-activated P2Y _(2)R in inflammasome activation. In addition, TNF-α and ATP increased the invasive and colony-forming ability of the MDA-MB-231 and RT-R-MDA-MB-231 cells, and these effects were caspase-1-dependent. Moreover, matrix metalloproteinase (MMP)-9 activity was modulated by caspase-1, in a P2Y _(2)R-dependent manner in the MDA-MB-231 and RT-R-MDA-MB-231 cells. Finally, nude mice injected with the RT-R-MDA-MB-231-EV cells (transfected with the empty vector) exhibited increased tumor growth, and higher levels of MMP-9 in their tumors and IL-1β levels in their serum compared with the mice injected with the RT-R-MDA-MB-231- P2Y _(2)R shRNA cells (transfected with P2Y _(2)R shRNA). On the whole, the findings of this study suggest that extracellular ATP promotes tumor progression in RT-R-breast cancer cells and breast cancer cells by modulating invasion and associated molecules through the P2Y _(2)R-inflammasome activation pathway.
机译:在肿瘤微环境中,细胞外核苷酸被释放并积累,并可以激活P2Y_(2)受体(P2Y_(2)R),后者调节肿瘤细胞中的各种反应,从而导致肿瘤进展和转移。此外,最近已经报道炎性体与肿瘤进展有关。但是,P2Y _(2)R在乳腺癌细胞中炎性体活化中的作用尚未明确。因此,在这项研究中,我们调查了P2Y _(2)R在使用炎症细胞和耐放射治疗(RT-R)乳腺癌细胞的炎症小体介导的肿瘤进展中的作用。我们通过重复照射(每次2 Gy,25次)建立了RT-R乳腺癌细胞(RT-R-MDA-MB-231,RT-R-MCF-7和RT-R-T47D细胞)。研究。在这项研究中,我们发现RT-R乳腺癌细胞表现出增加的释放三磷酸腺苷(ATP)和P2Y _(2)R活性。特别地,源自高度转移的MDA-MB-231细胞的RT-R-MDA-MB-231细胞表现出明显增加的ATP释放,其被肿瘤坏死因子(TNF)-α增强。用caspase-1活性和TNF-α和ATP处理后的白细胞介素(IL)-1β分泌来测量,MDA-MB-231细胞表现出炎性体激活。这些效应在RT-R-MDA-MB-231细胞中得到增强。然而,在MDA-MB-231和MDA-MB-231中,P2Y _(2)R敲低或存在腺苷三磷酸双磷酸酶,可显着降低因TNF-α或ATP处理而诱导的caspase-1活性增加和IL-1β分泌水平降低。 RT-R-MDA-MB-231细胞,提示ATP激活的P2Y _(2)R与炎症小体激活有关。此外,TNF-α和ATP增加了MDA-MB-231和RT-R-MDA-MB-231细胞的侵袭和集落形成能力,这些作用是caspase-1依赖性的。此外,在MDA-MB-231和RT-R-MDA-MB-231细胞中,胱天蛋白酶1以P2Y _(2)R依赖性方式调节基质金属蛋白酶(MMP)-9的活性。最后,注射RT-R-MDA-MB-231-EV细胞(用空载体转染)的裸鼠表现出增加的肿瘤生长,并且其肿瘤中MMP-9水平和血清IL-1β水平更高注射RT-R-MDA-MB-231- P2Y_(2)R shRNA细胞(转染P2Y_(2)R shRNA)的小鼠。总体而言,这项研究的发现表明,细胞外ATP通过调节P2Y_(2)R-炎症小体激活途径的侵袭和相关分子,促进RT-R乳腺癌细胞和乳腺癌细胞的肿瘤进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号